血管质量倡议中血管腔内主动脉修复术后胸腹主动脉瘤改变生活事件
基于血管质量倡议登记2011年1月至2022年5月数据,比较不同血管腔内主动脉修复类型术后胸腹主动脉瘤改变生活事件(TALE)发生率,并识别与TALE独立相关的解剖和手术因素。TALE在肾下型EVAR、复杂EVAR、TEVAR、I-III型TAAA修复和弓部修复中的发生率分别为1.2%、4.8%、6.0%、10%和14%,更近端锚定区、主动脉直径>65 mm、平行移植技术和术前慢性肾病与TALE风险升高相关。
要点
- TALE在肾下型EVAR中发生率1.2%,复杂EVAR中4.8%,TEVAR中6.0%,I-III型TAAA修复中10%,弓部修复中14%。
- 更近端锚定区、主动脉直径>65 mm、平行移植技术和术前慢性肾病与TALE风险升高相关。
- TALE及其组成部分可用于评估所有主动脉修复的疗效和术前咨询。
核心结论
- TALE虽最初用于描述TAAA修复,但也可发生于复杂EVAR、TEVAR和弓部修复之后。
- TALE及其组成部分应被用于评估所有主动脉修复的疗效及术前咨询。
- 外科医生应了解与TALE风险升高相关的解剖和手术特征,并将术中可能需要此类干预纳入患者术前风险评估。
研究设计与样本
- 回顾性分析血管质量倡议登记中2011年1月至2022年5月期间接受EVAR的患者。
- 患者按修复类型分层:肾下型EVAR 52,592例,复杂EVAR 3,768例,TEVAR 3,899例,I-III型TAAA修复1,139例,弓部修复479例。
- 主要结局为术后TALE,定义为术后死亡、透析、瘫痪和/或卒中的复合结局。
- 采用混合效应逻辑回归模型识别与TALE独立相关的手术和解剖因素。
主要发现
- TALE发生率:肾下型EVAR 1.2%,复杂EVAR 4.8%,TEVAR 6.0%,I-III型TAAA修复10%,弓部修复14%。
- 更近端锚定区与复杂EVAR(OR 1.9,95%CI 1.2-3.1,P=0.008)、TEVAR(OR 2.2,95%CI 1.4-3.5,P=0.001)和I-III型TAAA修复(OR 2.7,95%CI 1.5-4.9,P=0.001)后TALE风险升高相关。
- 主动脉直径>65 mm与肾下型EVAR(OR 1.8,95%CI 1.4-2.3,P<0.001)、复杂EVAR(OR 1.6,95%CI 1.1-2.3,P=0.010)、TEVAR(OR 2.7,95%CI 2.0-3.8,P<0.001)和弓部修复(OR 2.4,95%CI 1.3-4.4,P=0.007)后TALE风险升高相关。
- I-III型TAAA修复中使用平行移植技术(烟囱/潜望镜/镜筒)与TALE风险升高相关(OR 1.8,95%CI 1.1-3.2,P=0.032)。
- 术前慢性肾病与肾下型EVAR(OR 4.3,95%CI 3.0-5.7,P<0.001)、复杂EVAR(OR 5.2,95%CI 3.3-8.2,P<0.001)、TEVAR(OR 4.5,95%CI 2.8-7.1,P<0.001)和I-III型TAAA修复(OR 3.2,95%CI 1.6-6.7,P=0.001)后TALE风险升高相关。
关键数值与推荐
- TALE定义为术后死亡、透析、瘫痪和/或卒中的复合结局。
- TALE发生率分别为肾下型EVAR 1.2%、复杂EVAR 4.8%、TEVAR 6.0%、I-III型TAAA修复10%、弓部修复14%。
临床怎么用
- TALE及其组成部分可用于评估所有主动脉修复的疗效。
- TALE及其组成部分可用于术前咨询。
- 外科医生应了解与TALE风险升高相关的解剖和手术特征。
- 术中可能需要此类干预应纳入患者术前风险评估。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Endovascular aortic aneurysm repair (EVAR) has lower rates of postoperative mortality and morbidity when compared with open repair. However, endovascular repair still carries the risk of postoperative dialysis, paralysis, and stroke. This study examined the rates of postoperative mortality and morbidity stratified by type of endovascular aortic aneurysm repair. METHODS: All patients who underwent EVAR in the Vascular Quality Initiative registry from January 2011 to May 2022 were identified. Patients were stratified by repair type: infrarenal EVAR, complex EVAR, thoracic endovascular aortic repair (TEVAR), extent I to III thoracoabdominal aortic aneurysm (TAAA) repair, or aortic arch repair. The primary outcome was postoperative thoracoabdominal aortic aneurysm life-altering events (TALE) across the different treatment groups. TALE was defined as a composite outcome of postoperative mortality, dialysis, paralysis, and/or stroke. Mixed effect logistic regression modeling was used to identify procedural and anatomic factors that were independently associated with TALE. RESULTS: A total of 52,592 EVARs, 3768 complex EVARs, 3899 TEVARs, 1139 extent I to III TAAA repairs, and 479 arch repairs were identified. TALE was observed in 1.2% of EVARs, 4.8% of complex EVARs, 6.0% of TEVARs, 10% of extent I to III TAAA repairs, and 14% of arch repairs. More proximal landing zone was associated with higher odds of TALE after complex EVAR (odds ratio [OR], 1.9; 95% confidence interval [CI], 1.2-3.1; P = .008), TEVAR (OR, 2.2; 95% CI, 1.4-3.5; P = .001), and extent I to III TAAA repair (OR, 2.7; 95% CI, 1.5-4.9; P = .001). Aortic diameter >65 mm was associated with higher odds of TALE after infrarenal EVAR (OR, 1.8; 95% CI, 1.4-2.3; P < .001), complex EVAR (OR, 1.6; 95% CI, 1.1-2.3; P = .010), TEVAR (OR, 2.7; 95% CI, 2.0-3.8; P < .001), and arch repair (OR, 2.4; 95% CI, 1.3-4.4; P = .007). The use of parallel grafting technique (chimney/snorkel/periscope) during extent I to III TAAA repair was also associated with higher odds of TALE (OR, 1.8; 95% CI, 1.1-3.2; P = .032). Preoperative chronic kidney disease was also associated with higher odds of TALE after infrarenal EVAR (OR, 4.3; 95% CI, 3.0-5.7; P < .001), complex EVAR (OR, 5.2; 95% CI, 3.3-8.2; P < .001), TEVAR (OR, 4.5; 95% CI, 2.8-7.1; P < .001), and extent I to III TAAA repair (OR, 3.2; 95% CI, 1.6-6.7; P = .001). CONCLUSIONS: Although TALE was originally described for TAAA repairs, TALE may occur after complex EVAR, TEVAR, and arch repairs as well. Therefore, TALE and its component parts should be used to evaluate the efficacy of all aortic repairs and for preoperative counseling. Additionally, surgeons should be aware of anatomic and procedural characteristics that are associated with higher odds of TALE. The anticipated need for such interventions during aortic repair should be factored into preoperative risk assessment of patients.
引用
- Patel PB, Marcaccio CL, Swerdlow NJ, et al. Thoracoabdominal aortic aneurysm life-altering events following endovascular aortic repair in the Vascular Quality Initiative. J Vasc Surg. 2023. PMID: 37044316. doi:10.1016/j.jvs.2023.03.499
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。